The groundbreaking success of Viagra undeniably transformed the drug landscape, but placing funds in companies primarily reliant on off-patent versions presents a complex picture. Although early earnings were impressive, the cessation of patents and the appearance of less expensive alternatives have eroded sales. Therefore, a thorough analysis of p